Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01733966Phase 3Terminated
A Phase 3 trial of secnidazole in sigmoid diverticulitis, sponsored by Quanta Medical. Started May 2010; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01733966.